CMS is proposing expanding coverage of digital health devices used in some behavioral health treatment programs and asking for comments on adding even more devices. But will that be enough to spur ...

Sens. Shelley Moore Capito, R-W.Va, and Jeanne Shaheen, D-N.H., have reintroduced a bill that would expand access to software-based treatments and create a reimbursement pathway for software that ...

Editor's Note: This story has been updated with additional quotes from Pear Therapeutics. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division ...

The precise definition of digital therapeutics has been a hot topic as the new technology category has been discussed and debated in event sessions and articles over the last few years. Now the ...

In this episode, Dr. Edo Paz, Senior Vice President of Medical Affairs, and Victoria Andrews, RNP, Senior Director of Solutions Consulting at Hello Heart, join us to discuss digital therapeutics and ...

Panelists discuss how insurance coverage for prescription digital therapeutics remains uneven due to uncertain reimbursement pathways, lack of awareness among health care leaders, challenges in ...

It’s been a buzzy few years for prescription digital therapeutics, marked by bankruptcies, reimbursement policy changes and AI advancements. At their best, DTx solutions can offer a more personalized, ...

Panelists discuss how prescription digital therapeutics differ from traditional pharmaceuticals by following FDA medical device approval pathways focused on clinical performance and safety rather than ...

Several digital therapeutics (DTx) — evidence-based interventions delivered via mobile app or web-based platforms — could help patients with irritable bowel syndrome (IBS), according to a new review ...

German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...